Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis.
Oliver D, Arribas M, Radua J, Salazar de Pablo G, De Micheli A, Spada G, Mensi MM, Kotlicka-Antczak M, Borgatti R, Solmi M, Shin JI, Woods SW, Addington J, McGuire P, Fusar-Poli P. Oliver D, et al. Among authors: addington j. Mol Psychiatry. 2022 Sep;27(9):3670-3678. doi: 10.1038/s41380-022-01611-w. Epub 2022 Jun 3. Mol Psychiatry. 2022. PMID: 35665763 Free PMC article.
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.
McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, Hawkins KA, Hoffman R, Lindborg S, Tohen M, Breier A. McGlashan TH, et al. Among authors: addington j. Schizophr Res. 2003 May 1;61(1):7-18. doi: 10.1016/s0920-9964(02)00439-5. Schizophr Res. 2003. PMID: 12648731 Clinical Trial.
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH. Miller TJ, et al. Among authors: addington d, addington j. Schizophr Res. 2003 May 1;61(1):19-30. doi: 10.1016/s0920-9964(02)00440-1. Schizophr Res. 2003. PMID: 12648732 Clinical Trial.
Factorial structure of the Scale of Prodromal Symptoms.
Hawkins KA, McGlashan TH, Quinlan D, Miller TJ, Perkins DO, Zipursky RB, Addington J, Woods SW. Hawkins KA, et al. Among authors: addington j. Schizophr Res. 2004 Jun 1;68(2-3):339-47. doi: 10.1016/S0920-9964(03)00053-7. Schizophr Res. 2004. PMID: 15099615
Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.
McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A. McGlashan TH, et al. Among authors: addington d, addington j. Am J Psychiatry. 2006 May;163(5):790-9. doi: 10.1176/ajp.2006.163.5.790. Am J Psychiatry. 2006. PMID: 16648318 Clinical Trial.
Recruitment and treatment practices for help-seeking "prodromal" patients.
McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, Penn D, Perkins D, Salokangas RK, Walsh B, Woods SW, Yung A. McGlashan TH, et al. Among authors: addington j. Schizophr Bull. 2007 May;33(3):715-26. doi: 10.1093/schbul/sbm025. Epub 2007 May 4. Schizophr Bull. 2007. PMID: 17483100 Free PMC article.
Social functioning in individuals at clinical high risk for psychosis.
Addington J, Penn D, Woods SW, Addington D, Perkins DO. Addington J, et al. Among authors: addington d. Schizophr Res. 2008 Feb;99(1-3):119-24. doi: 10.1016/j.schres.2007.10.001. Epub 2007 Nov 19. Schizophr Res. 2008. PMID: 18023329 Free PMC article.
442 results